Position in HALO
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$84,771,262
+$40,851,106 QoQ
Shares Held
1,083,062
+59.4% QoQ
Ownership
0.954%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#36
of 664 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Boston Trust Walden Corp holds $230,816,361 across 5 Biotechnology names. HALO ranks #2 (36.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
443,123 | $106,779,348 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
This page
|
1,083,062 | $84,771,262 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
440,264 | $38,280,954 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,193 | $743,883 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
485 | $240,914 |
All Filings in HALO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,771,262 | 1,083,062 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $43,920,156 | 679,563 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $52,617,494 | 781,835 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $61,157,711 | 833,893 | Shares | Defined | 2025-10-17 | |
| 2025-06-30 | $43,969,696 | 845,246 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $55,315,101 | 866,872 | Shares | Defined | 2025-04-21 | |
| 2024-12-31 | $41,789,812 | 874,081 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $39,072,939 | 682,616 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $23,210,926 | 443,295 | Shares | Defined | 2024-07-19 | |
| No filing history on record for this holder in this stock. | ||||||